Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Computational modeling identifies protective mechanisms of estrogen and testosterone against atrial fibrosis.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Mapping the Brain Interaction Network of the Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Targeted by Leucettinib-21 Using Affinity Chromatography.

ACS pharmacology & translational science·2026
Same author

Nitrogen-Doped Graphene Quantum Dots Conjugated to Leucettinib-21 Rescue Differentiating Zebrafish Purkinje Cells by Inhibiting Dyrk1A Kinase.

ACS applied nano materials·2026
Same author

Semaglutide Reverses Ectopic Lipid Accumulation, Impaired Myocardial Perfusion Reserve, and Diastolic Dysfunction in a Mouse Model of Cardiometabolic Heart Disease.

JACC. Basic to translational science·2026
Same author

A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy.

Cell·2026
Same author

Cerebrospinal Fluid Metagenomic Next-Generation Sequencing in Pediatric Central Nervous System Infection: Clinical Experience and Diagnostic Stewardship Strategies.

Open forum infectious diseases·2026

相关实验视频

Updated: May 5, 2026

Creating a Structurally Realistic Finite Element Geometric Model of a Cardiomyocyte to Study the Role of Cellular Architecture in Cardiomyocyte Systems Biology
08:54

Creating a Structurally Realistic Finite Element Geometric Model of a Cardiomyocyte to Study the Role of Cellular Architecture in Cardiomyocyte Systems Biology

Published on: April 18, 2018

9.8K

网络建模预测DYRK1A抑制如何促进缺血/再生损伤后的心肌细胞循环

Bryce C Murillo, Alexander Young, Kaitlyn L Wintruba

    bioRxiv : the preprint server for biology
    |September 3, 2025
    PubMed
    概括

    通过使心肌细胞循环重新进入,抑制DYRK1A可促进心肌梗塞后的心脏再生. 这种方法改善了心脏功能,

    更多相关视频

    Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
    07:23

    Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

    Published on: March 7, 2022

    6.2K
    An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
    09:29

    An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice

    Published on: July 14, 2023

    903

    相关实验视频

    Last Updated: May 5, 2026

    Creating a Structurally Realistic Finite Element Geometric Model of a Cardiomyocyte to Study the Role of Cellular Architecture in Cardiomyocyte Systems Biology
    08:54

    Creating a Structurally Realistic Finite Element Geometric Model of a Cardiomyocyte to Study the Role of Cellular Architecture in Cardiomyocyte Systems Biology

    Published on: April 18, 2018

    9.8K
    Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
    07:23

    Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

    Published on: March 7, 2022

    6.2K
    An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
    09:29

    An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice

    Published on: July 14, 2023

    903

    科学领域:

    • 心血管生物学
    • 分子心脏病学
    • 复原医学

    背景情况:

    • 成年哺乳动物的心脏再生受到心肌细胞增殖的限制.
    • 双特异氨酸酸化调节激酶1A (DYRK1A) 调节细胞静止,但其在心肌细胞中的确切作用尚不清楚.
    • 在心肌梗塞 (MI) 后,药理上的DYRK1A抑制已经显示出促进心肌细胞循环的潜力.

    研究的目的:

    • 阐明DYRK1A抑制促进心肌细胞循环重新进入的机制.
    • 在临床前的心脏损伤模型中验证DYRK1A抑制的治疗潜力.

    主要方法:

    • 通过DYRK1A调节细胞周期的计算网络模型的开发.
    • 在新生小鼠心肌细胞 (NRCMs) 中测试选择性DYRK1A抑制剂.
    • 网络模型与大量RNA测序数据的整合以及使用小鼠缺血/再输血 (I/R) MI模型的体内研究.

    主要成果:

    • 计算模型预测了DYRK1A抑制在心肌细胞循环重新进入中的作用.
    • 在NRCM中强烈诱导DYRK1A抑制剂的细胞循环活性.
    • E2F1被确定为细胞周期基因表达的关键转录驱动因素.
    • 药理和发育后的DYRK1A抑制改善了心脏功能,增加了心肌细胞循环后的I/ RMI.

    结论:

    • 抑制DYRK1A是一种可行的策略,可以增强心肌细胞的增殖和心脏修复.
    • 这些发现突出显示E2F1是DYRK1A调节细胞周期进展的关键媒介.
    • 小分子抑制DYRK1A为治疗心肌梗塞提供了一个有前途的治疗途径.